Session 17: FDA Approved Medications for Weight Loss

Wednesday, November 30, 2022, 12:30 PM - 1:45 PM, Webinar (Online)

AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician (1.00 hours)

Date and Time: Session 17: Wednesday, November 30th, 2022 @ 12:30pm-1:45pm PST 
Zoom Webinar ID: 976 0959 8851 
Webinar Link: https://washington.zoom.us/j/97609598851

Talk Title: FDA Approved Medications for Weight Loss

To go back to the main course page, please click here.

Accreditation with Commendation: The University of Washington School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation: The University of Washington School of Medicine designates this other activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ACPE #: 0130-9999-22-473-H01-P
0130-9999-22-473-L01-P

Bharti Shetye, MD (Dr. Abby) is a weight loss specialist certified by the American Board of Obesity Medicine. She is also trained as a primary care physician certified by the American Board of Internal Medicine. Dr. Abby joined Sun Coast Bariatrics, a bariatric surgical center of excellence, as the medical director in 2016. The success of her program has been showcased by the National Association of City & Health Officials (NACCHO) in Washington DC as a “national model clinic.” She has presented at local and national meetings of the Obesity Medicine Association and the Southern Obesity Summit.  Dr. Abby has two goals for all her patients – short term success to reach goal weight at present and long-term success to prevent the yo-yo pattern of weight loss and weight gain moving forward. She works passionately with recommendations toward diet, exercise, and lifestyle changes and behavioral modification to achieve both goals.

Speaker Disclosure(s): none

Planner Disclosure(s):

• Dr. Nicole Ehrhardt, MD is on the Advisory board for Dexcom and Novo Nordisk; Educational Grant: Novo Nordisk and Merck; Investigator: Dexcom
• Dr. Savitha Subramanian, MD is on the advisory board for Abbott Diabetes Care and was formerly on the Advisory board for Akcea Therapeutics and Amarni.
• Laura Montour, MD: none
• Lorena Casas-Wright, MD: none
• Nayan Arora, MD: none

All relevant financial relationships have been mitigated.

Mitigation of Relevant Financial Relationships

University of Washington School of Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Wednesday, November 30, 2022

We would like to acknowledge support in the form of an educational grant from NovoNordisk.